Latest News and Press Releases

Aptose Reports Third Quarter 2025 Results

PRESS RELEASE AI-discovered candidate CHM-029 demonstrates robust, dose-dependent tumor regression in pre-clinical AML models and retains potency against all known resistance mutationsFirst-in-human...

Juniper Research today unveiled their Top 10 Fintech & Payments Trends 2026 - a definitive look at the market shifts set to reshape financial services.

Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and Provides 2025–2026 Financial Guidance Positive Free Cash Flow (+€0,01 mm) over the last 12 months in terms of constant...

AGOURA HILLS, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative...

Facephi Unveils its Fraud Intelligence Report 2025: “Identity at Risk” Cybercrime is projected to cost US$10.5 trillion annually by 20251.Identity theft accounted for 47% of reported financial fraud...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Customer Due Diligence (CDD) Services Market Report 2025" has been added to ResearchAndMarkets.com's offering. The customer due diligence (CDD)...

AMX-883 uses Amphista’s Targeted Glue™ technology, inducing degradation of BRD9 through the recruitment of DCAF16, a completely distinct mechanism of action from cereblon- or VHL-based PROTACs. The...

Juniper Research is excited to announce the winners of the Future Digital Awards for Fintech & Payments 2025.

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to accelerate time to treatment OTS product was well...